Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Seneca

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Nuclear Medicine and Biology|February 22, 2005
Preparation of highly specific radioactivity [18F]flumazenil and its evaluation in cynomolgus monkey by positron emission tomographyNikolaj N Ryzhikov, Nicholas Seneca, Raisa N Krasikova, et al.
Annals of Clinical and Translational Neurology|December 11, 2014
Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brainDaniel C Anthony, Alex M Dickens, Nicholas Seneca, et al.
Synapse (New York, N.Y.)|June 21, 2008
Kinetic brain analysis and whole-body imaging in monkey of [11C]MNPA: a dopamine agonist radioligandNicholas Seneca, Mette Skinbjerg, Sami S Zoghbi, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Development of new brain imaging agents based upon nocaine-modafinil hybrid monoamine transporter inhibitorsJohn L Musachio, Jinsoo Hong, Masanori Ichise, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2016
Kinetic Modeling of the Tau PET Tracer <sup>18</sup>F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease SubjectsOlivier Barret, David Alagille, Sandra Sanabria, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2010
Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomographyGarth E Terry, Jussi Hirvonen, Jeih-San Liow, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 13, 2009
Neuroimaging and physiological evidence for involvement of glutamatergic transmission in regulation of the striatal dopaminergic systemMasaki Tokunaga, Nicholas Seneca, Ryong-Moon Shin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 17, 2016
Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragilineStefan Sturm, Anton Forsberg, Stephane Nave, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 3, 2015
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areasEunkyung Park, Jean-Dominique Gallezot, Aracely Delgadillo, et al.
Neuroimage|April 25, 2008
[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brainM Edward Pierson, Jan Andersson, Svante Nyberg, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Nuclear Medicine and Biology|February 22, 2005
Preparation of highly specific radioactivity [18F]flumazenil and its evaluation in cynomolgus monkey by positron emission tomographyNikolaj N Ryzhikov, Nicholas Seneca, Raisa N Krasikova, et al.
Annals of Clinical and Translational Neurology|December 11, 2014
Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brainDaniel C Anthony, Alex M Dickens, Nicholas Seneca, et al.
Synapse (New York, N.Y.)|June 21, 2008
Kinetic brain analysis and whole-body imaging in monkey of [11C]MNPA: a dopamine agonist radioligandNicholas Seneca, Mette Skinbjerg, Sami S Zoghbi, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Development of new brain imaging agents based upon nocaine-modafinil hybrid monoamine transporter inhibitorsJohn L Musachio, Jinsoo Hong, Masanori Ichise, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2016
Kinetic Modeling of the Tau PET Tracer <sup>18</sup>F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease SubjectsOlivier Barret, David Alagille, Sandra Sanabria, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2010
Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomographyGarth E Terry, Jussi Hirvonen, Jeih-San Liow, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 13, 2009
Neuroimaging and physiological evidence for involvement of glutamatergic transmission in regulation of the striatal dopaminergic systemMasaki Tokunaga, Nicholas Seneca, Ryong-Moon Shin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 17, 2016
Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragilineStefan Sturm, Anton Forsberg, Stephane Nave, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 3, 2015
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areasEunkyung Park, Jean-Dominique Gallezot, Aracely Delgadillo, et al.
Neuroimage|April 25, 2008
[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brainM Edward Pierson, Jan Andersson, Svante Nyberg, et al.
Pageof 4